2.94
price up icon58.92%   1.09
after-market After Hours: 2.86 -0.08 -2.72%
loading
Precigen Inc stock is traded at $2.94, with a volume of 172.87M. It is up +58.92% in the last 24 hours and up +58.92% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$1.85
Open:
$2.6
24h Volume:
172.87M
Relative Volume:
35.00
Market Cap:
$867.83M
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-7.5385
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
+65.17%
1M Performance:
+58.92%
6M Performance:
+50.00%
1Y Performance:
+174.77%
1-Day Range:
Value
$2.51
$3.4899
1-Week Range:
Value
$1.70
$3.4899
52-Week Range:
Value
$0.6513
$3.4899

Precigen Inc Stock (PGEN) Company Profile

Name
Name
Precigen Inc
Name
Phone
301-556-9900
Name
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Employee
25
Name
Twitter
@precigen
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PGEN
Precigen Inc
2.94 551.25M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-22-24 Downgrade JP Morgan Neutral → Underweight
May-23-23 Initiated JP Morgan Neutral
Nov-18-22 Initiated Cantor Fitzgerald Overweight
Feb-25-21 Initiated Stifel Buy
Feb-22-21 Initiated Wells Fargo Overweight
Feb-18-21 Initiated B. Riley Securities Buy
May-08-20 Initiated H.C. Wainwright Buy
View All

Precigen Inc Stock (PGEN) Latest News

pulisher
06:40 AM

Precigen’s Papzimeous Approval Allows US FDA CBER Director To Emphasize Flexibility - insights.citeline.com

06:40 AM
pulisher
01:32 AM

Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos - Quiver Quantitative

01:32 AM
pulisher
12:32 PM

FDA Grants Full Approval to Precigen’s Papzimeos for Recurrent Respiratory Papillomatosis - PharmExec

12:32 PM
pulisher
11:34 AM

Precigen shares jump after US FDA approves first therapy for rare respiratory disease - Reuters

11:34 AM
pulisher
11:09 AM

Precigen stock soars after FDA approves first RRP treatment - Investing.com

11:09 AM
pulisher
11:00 AM

A speedy FDA approval for Precigen’s rare disease gene therapy - BioWorld MedTech

11:00 AM
pulisher
10:14 AM

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga

10:14 AM
pulisher
10:04 AM

Precigen’s Remarkable Uptick: What Drives It? - StocksToTrade

10:04 AM
pulisher
10:01 AM

US FDA approves Precigen's immunotherapy for rare respiratory disease - Reuters

10:01 AM
pulisher
09:48 AM

Why Is Precigen Stock Surging On Friday? - inkl

09:48 AM
pulisher
09:32 AM

Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis - BioSpace

09:32 AM
pulisher
09:21 AM

Precigen, Twilio, Hims & Hers - TradingView

09:21 AM
pulisher
09:19 AM

Precigen Shares on the Rise: Is Now the Time to Invest? - timothysykes.com

09:19 AM
pulisher
08:55 AM

Precigen scores FDA nod for first-ever treatment for HPV-related disorder - Fierce Pharma

08:55 AM
pulisher
08:07 AM

Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy - TipRanks

08:07 AM
pulisher
08:01 AM

Precigen Stock Shot Through The Roof On Friday Morning – Here’s Why - Stocktwits

08:01 AM
pulisher
07:24 AM

Precigen announces full FDA approval of Papzimeos - MarketScreener

07:24 AM
pulisher
07:21 AM

Precigen stock surges on FDA approval (update) (PGEN:NASDAQ) - Seeking Alpha

07:21 AM
pulisher
07:20 AM

Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial - Yahoo Finance

07:20 AM
pulisher
07:00 AM

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

07:00 AM
pulisher
05:00 AM

FDA clears Precigen's rare tumour immunotherapy - pharmaphorum

05:00 AM
pulisher
02:01 AM

Is Precigen Inc. exposed to political riskJuly 2025 Macro Moves & Smart Investment Allocation Insights - thegnnews.com

02:01 AM
pulisher
12:27 PM

Precigen earnings missed, revenue topped estimates - Investing.com

12:27 PM
pulisher
12:26 PM

Precigen earnings missed, revenue topped estimates By Investing.com - Investing.com Canada

12:26 PM
pulisher
Aug 13, 2025

Precigen 2025 Q2 Earnings Significant Net Loss Reduction - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Precigen (PGEN) Analyst Rating Reiterated by HC Wainwright & Co. - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Precigen, Inc. Reports Q2 2025 Earnings and Strategic Focus - TipRanks

Aug 13, 2025
pulisher
Aug 11, 2025

Quant Funds Rotate Into Precigen Inc. StockMarket Surge Signal for Swing Traders Triggered - beatles.ru

Aug 11, 2025
pulisher
Aug 09, 2025

Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace

Aug 09, 2025
pulisher
Aug 08, 2025

Precigen Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Precigen Inc. stockRobust investment performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Precigen Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Precigen Inc. stock priceNavigate market volatility with smart strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Precigen Inc. stock expected to show significant growthPhenomenal returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Precigen Inc. generate profit in a changing economyInvest in stocks with long-term growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Precigen Inc. stock compared to the marketAchieve rapid wealth accumulation with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Precigen Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Precigen Inc. Stock Analysis and ForecastInvest in stocks with long-term growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Precigen Inc. company’s balance sheetInvest confidently with professional advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Precigen Inc. compare to its industry peersSuperior trading gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Precigen Inc. stock in 2025Remarkable growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What catalysts could drive Precigen Inc. stock higher in 2025Grow your wealth with proven stock picks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Precigen Inc. a growth stock or a value stockHigh-profit stock alerts - Jammu Links News

Aug 02, 2025
pulisher
Jul 31, 2025

Ranking Precigen Inc. among high performing stocks via toolsNews Based Entry Opportunity Alerts Detected - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

Precigen Inc. Stock Seesawing Amid Market Uncertainty - timothysykes.com

Jul 30, 2025
pulisher
Jul 30, 2025

Can Precigen Stock Continue Its Rollercoaster? - StocksToTrade

Jul 30, 2025
pulisher
Jul 30, 2025

Is Precigen Inc. a Top Dividend Stock to Watch in 2025Smart Trade Plans With Risk Protection Explained - metal.it

Jul 30, 2025
pulisher
Jul 28, 2025

Intraday Charts Show Spike in Precigen Inc. ActivityMulti-Bagger Potential Stock Forecast Tools Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are Precigen Inc. company’s key revenue driversCapitalize on fast-moving stock trends - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Precigen Inc.Invest confidently with professional market insights - Jammu Links News

Jul 28, 2025

Precigen Inc Stock (PGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Cap:     |  Volume (24h):